U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C5H12O2
Molecular Weight 104.1476
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PENTYLENE GLYCOL

SMILES

CCCC(O)CO

InChI

InChIKey=WCVRQHFDJLLWFE-UHFFFAOYSA-N
InChI=1S/C5H12O2/c1-2-3-5(7)4-6/h5-7H,2-4H2,1H3

HIDE SMILES / InChI

Molecular Formula C5H12O2
Molecular Weight 104.1476
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
ERASE IT KIT

Approved Use

USE FOR TREATMENT OF ACNE
PubMed

PubMed

TitleDatePubMed
A practical total synthesis of (+)-spirolaxine methyl ether.
2010-12-03
Influence of polyols on the formation of iron oxide nanoparticles in solvothermal system.
2010-12
Internally protected amino sugar equivalents from enantiopure 1,2-oxazines: synthesis of variably configured carbohydrates with C-branched amino sugar units.
2010-10-18
Allergic contact dermatitis to propyl gallate and pentylene glycol in an emollient cream.
2010-05
Reactivity of poly-alcohols towards OH, NO3 and SO4- in aqueous solution.
2009-11-07
1,4-Butanediol content of aqua dots children's craft toy beads.
2009-09
The shape evolution of gold seeds and gold@silver core-shell nanostructures.
2009-07-29
Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial.
2009-07
Fabrication and characterization of ophthalmically compatible hydrogels composed of poly(dimethyl siloxane-urethane)/Pluronic F127.
2009-06-01
Experimental stroke protection induced by 4-hydroxybenzyl alcohol is cancelled by bacitracin.
2009-06
Transferable force field for alcohols and polyalcohols.
2009-04-30
Chemoselective hydrogenolysis of tetrahydrofurfuryl alcohol to 1,5-pentanediol.
2009-04-21
In vitro activity of chlorhexidine and pentane-1,5-diol and their combination on Candida albicans, Staphylococcus aureus and Propionibacterium acnes.
2009
Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1.
2009
Effect of pentane-1,5-diol and propane-1,2-diol on percutaneous absorption of terbinafine.
2009
Thermal properties and mixing state of diol-water mixtures studied by calorimetry, large-angle X-ray scattering, and NMR relaxation.
2008-10-23
A comparison of pentane-1,5-diol to other diols for use in dermatology.
2008-04
Synthesis of phosphate monomers and bonding to dentin: esterification methods and use of phosphorus pentoxide.
2008-03
Allergic contact dermatitis to pentylene glycol in a cosmetic cream.
2008-02
Polyhedral gold nanocrystals with O h symmetry: from octahedra to cubes.
2006-11-22
Bioconjugatable porphyrins bearing a compact swallowtail motif for water solubility.
2006-05-18
Treatment of atopic dermatitis with 1% hydrocortisone and 25% pentane-1,5-diol: effect on Staphylococcus aureus.
2006
MD simulations of the binding of alcohols and diols by a calixarene in water: connections between microscopic and macroscopic properties.
2005-12-15
Pentane-1,5-diol as a percutaneous absorption enhancer.
2005-12
Total synthesis of the epoxy isoprostane phospholipids PEIPC and PECPC.
2005-09-01
Chemical toxicity correlations for several fish species based on the Abraham solvation parameter model.
2005-09
The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage?
2005
Design, synthesis, and evaluation of mixed imine-amine pyrrolobenzodiazepine dimers with efficient DNA binding affinity and potent cytotoxicity.
2004-10-15
Identification of the several new radicals formed in the reaction mixture of oxidized linoleic acid with ferrous ions using HPLC-ESR and HPLC-ESR-MS.
2003-09
Adenosine-5'-O-phosphorylated and adenosine-5'-O-phosphorothioylated polyols as strong inhibitors of (symmetrical) and (asymmetrical) dinucleoside tetraphosphatases.
2003-07-15
[Bactericidal effects of commonly used antiseptics/disinfectants on nosocomial bacterial pathogens and the relationship between antibacterial and biocide resistance].
2003-07-04
Allergic contact dermatitis from pentylene glycol in an emollient cream, with possible co-sensitization to resveratrol.
2003-03
Continuous monitoring of prostatic acid phosphatase using self-indicating substrates.
2002-12
Design, synthesis, and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity.
2002-10-10
Effects of aldehydes and methods of cross-linking on properties of calcium alginate microspheres prepared by emulsification.
2002-03
Stereocontrolled total synthesis of the Stemona alkaloid (-)-stenine.
2001-10-01
Aerobic and anaerobic metabolism of glutaraldehyde in a river water-sediment system.
2001-10
Ecotoxicology of glutaraldehyde: review of environmental fate and effects studies.
2001-05
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:09:20 GMT 2025
Edited
by admin
on Mon Mar 31 18:09:20 GMT 2025
Record UNII
50C1307PZG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(±)-1,2-PENTANEDIOL
Preferred Name English
PENTYLENE GLYCOL
INCI  
INCI  
Official Name English
1,2-PENTANEDIOL
Systematic Name English
1,2-DIHYDROXYPENTANE
Systematic Name English
Pentylene glycol [WHO-DD]
Common Name English
NSC-513
Code English
Code System Code Type Description
ECHA (EC/EINECS)
226-285-3
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
SMS_ID
100000086317
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
PUBCHEM
93000
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
NSC
513
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
WIKIPEDIA
Pentylene glycol
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
EVMPD
SUB22604
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
EPA CompTox
DTXSID10863522
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
CAS
5343-92-0
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
FDA UNII
50C1307PZG
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
MESH
C452500
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
DAILYMED
50C1307PZG
Created by admin on Mon Mar 31 18:09:20 GMT 2025 , Edited by admin on Mon Mar 31 18:09:20 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY